‘Gamechanger’ brought in after success of trial offering larger doses of drugs within first two weeks of treatment
People in Britain with heart failure are being given larger doses of drugs at the start of their treatment after a global study found that this led to a huge fall in deaths.
Experts say the new approach could mean those with the potentially fatal condition start receiving their ideal amount of medication within two weeks of diagnosis rather than after many months.
Continue reading…
